Buscopan (Hyoscine Butylbromide) IV Dosing Frequency
For intravenous administration, Buscopan (hyoscine butylbromide) is given as a single dose of 20 mg, which can be repeated if necessary, with most clinical protocols allowing repeat dosing at intervals ranging from immediately after initial assessment to several hours later, though the FDA-approved veterinary label specifies a single injection protocol. 1
Standard IV Dosing
The typical intravenous dose for hyoscine butylbromide in clinical practice is:
- Initial dose: 20 mg IV (given as a slow intravenous injection) 2, 3
- Alternative dose: 10-40 mg IV depending on indication and clinical response 4, 3
Dosing Frequency and Repeat Administration
Repeat dosing protocols vary by clinical indication:
Single dose administration is most common in procedural settings (endoscopy, imaging) where one injection of 10-20 mg is given before or during the procedure 4, 3
Repeat dosing for acute pain (renal colic, biliary colic): A second dose may be administered if pain relief is inadequate after 30 minutes, though specific time intervals between doses are not rigidly defined in the literature 2
Multiple doses during procedures: In colonoscopy studies, patients received 10 mg before insertion and an additional 10 mg at the cecum (total 20 mg over the procedure duration) 4
Clinical Considerations
Onset and duration of action:
- Pain relief is noticeable within 10 minutes of IV administration 2
- Peak effect occurs at 15-30 minutes 2, 5
- Duration of antispasmodic effect is relatively short, typically lasting 30-60 minutes 2
Common adverse effects include tachycardia (17.6% incidence in one study), mild anticholinergic symptoms (dry mouth, pupillary dilation), and transient reduction in bowel sounds—all self-limiting 4, 2
Important caveat: The short duration of action means that for sustained symptom control, repeat dosing may be necessary, but there is no established maximum frequency for IV administration in acute settings beyond general anticholinergic safety principles 2, 6